Other neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
Notes: Diffuse cutaneous mastocytosis ; Maculopapular cutaneous mastocytosis ; Solitary mastocytoma ; Telangiectasia macularis eruptiva perstans ; Urticaria pigmentosa ; Indolent systemic mastocytosis ; Isolated bone marrow mastocytosis ; Smoldering systemic mastocytosis ; Systemic mastocytosis, with an associated hematological non-mast cell lineage disease (SM-AHNMD) ; Extracutaneous mastocytoma ; Mast cell tumor NOS ; Mastocytoma NOS ; Mastocytosis NOS ; Chronic neutrophilic leukemia ; Myeloproliferative disease, unspecified ; Monoclonal gammopathy of undetermined significance [MGUS] ; Essential thrombocytosis ; Idiopathic hemorrhagic thrombocythemia ; Primary thrombocytosis ; Chronic idiopathic myelofibrosis ; Myelofibrosis (idiopathic) (with myeloid metaplasia) ; Myelosclerosis (megakaryocytic) with myeloid metaplasia ; Secondary myelofibrosis in myeloproliferative disease ; Histiocytic tumors of uncertain behavior ; Lymphoproliferative disease NOS ; congenital cutaneous mastocytosis (Q82.2) ; histiocytic neoplasms of uncertain behavior (D47.Z9) ; malignant mast cell neoplasm (C96.2-) ; congenital (diffuse) (maculopapular) cutaneous mastocytosis (Q82.2) ; congenital urticaria pigmentosa (Q82.2) ; extracutaneous mastocytoma (D47.09) ; aggressive systemic mastocytosis (C96.21) ; mast cell leukemia (C94.3-) ; atypical chronic myeloid leukemia BCR/ABL-negative (C92.2-) ; chronic myeloid leukemia BCR/ABL-positive (C92.1-) ; myelofibrosis NOS (D75.81) ; myelophthisic anemia (D61.82) ; myelophthisis (D61.82) ; secondary myelofibrosis NOS (D75.81) ; acute myelofibrosis (C94.4-) ; reactive thrombocytosis (D75.838) ; secondary thrombocytosis (D75.838) ; thrombocythemia NOS (D75.839) ; thrombocytosis NOS (D75.839) ; Kaposi’s sarcoma (C46.-) ; complications of transplanted organs and tissue (T86.-)